Yellowfin has signed an agreement in conjunction with Chinese
pharmaceuticals company Zuellig Pharma China.
As we welcome in the Chinese New year, and Year of the Pig, Yellowfin
looks forward to this auspicious partnership as the Yellowfin founder
shares his birthday in the Year of the Pig.
Under the agreement with Yellowfin, Zuellig Pharma China will provide
Yellowfin to their clients, which are predominantly hospitals.
Established in 1993, Zuellig Pharma China is a leading distributor of
multinational pharmaceuticals in China. With the vision to enter China
early, before the Chinese pharmaceutical distribution industry was
open to direct foreign investment, Zuellig Pharma China has been able
to build a formidable reputation for the highest standards in modern
pharmaceutical distribution.
"It is an exciting time as we expand further into more countries
abroad, China will give us great opportunities to build our global
reputation as well as building a number of new partnerships" said Glen
Rabie, CEO of Yellowfin.
This is a significant step for Yellowfin, and the beginning of the
company's entry into the Chinese market. An exciting new development
is that together with Zuellig Pharma assistance Yellowfin has been
localized for the Chinese market and is available in Simplified
Chinese.
"Yellowfin provides us with the functionality, ease of use and a
pricing structure that is sensitive to the local market. We are really
looking forward to developing this new partnership" Said David Howe,
IT Director of Zuellig Pharma.
Zuellig Pharma China plan to provide Yellowfin to their key clients
and through this, anticipate an increasing level of sales, customer
loyalty and satisfaction.
